A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously

NCT01297192 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Pharmacokinetics of Mirabegron

Interventions

DRUG: solifenacin succinate
DRUG: mirabegron

Sponsor

Astellas Pharma Inc